The associated journey ii bcs oxinium femoral component, journey ii bcs xlpe articular insert, genesis ii resurfacing patellar component and journey tibial baseplate were not returned for evaluation.It was reported that only the femoral component and the insert were revised.Our investigation including a review of complaint history for the revised parts revealed no prior complaints for the listed failure mode with the same batch number.A review of the manufacturing records of the femoral component and the insert did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.At this time, we have no reason to suspect that the product failed to meet any product specifications at the time of manufacture.Without the return of the actual product involved, our investigation of this report is inconclusive.A clinical evaluation noted that no relevant documentation was provided, therefore, a thorough medical investigation could not be performed.No further investigation is warranted for this complaint; however we will continue to monitor for future complaints and investigate as necessary.Should the device or additional information be received, the complaint will be reopened.
|